Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism
- PMID: 16450094
- DOI: 10.1007/s00134-005-0058-5
Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism
Abstract
Objective: Sildenafil has a well established pulmonary vasodilatory effect, but has seldom been used in critically ill patients. We report a case of severe recurrent pulmonary embolism in which sildenafil was used as a rescue therapy.
Results: After oral administration of 50 mg of sildenafil, cardiac index increased from 2.11/min/m(2) to 3.21/min/m(2); mean pulmonary artery pressure decreased from 56 mmHg to 46 mmHg, and pulmonary vascular resistance index decreased from 700 dynes/cm(-5)/m(2) to 425 dynes/cm(-5)/m(2), without reduction of arterial systemic pressure. Clinical condition also improved during the following days under treatment of 50 mg sildenafil three times daily.
Conclusions: These observations should stimulate studies with sildenafil in the ICU setting. Sildenafil is easy to administer in every ICU and at any time. If its potential is confirmed, it may be a life-saving drug in some emergency situations caused by severe pulmonary hypertension.
Comment in
-
The use of sildenafil in the therapy of massive pulmonary embolism.Intensive Care Med. 2006 Aug;32(8):1284. doi: 10.1007/s00134-006-0243-1. Epub 2006 Jun 21. Intensive Care Med. 2006. PMID: 16788805 No abstract available.
Similar articles
-
Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.Circ Heart Fail. 2012 Jan;5(1):47-53. doi: 10.1161/CIRCHEARTFAILURE.111.963314. Epub 2011 Nov 4. Circ Heart Fail. 2012. PMID: 22057829 Clinical Trial.
-
Should we administer sildenafil to patients with acute respiratory distress syndrome? No.Intensive Care Med. 2010 Jun;36(6):1102-3; author reply 1104-5. doi: 10.1007/s00134-010-1865-x. Epub 2010 Mar 24. Intensive Care Med. 2010. PMID: 20333352 No abstract available.
-
Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.Heart. 2011 Nov;97(22):1876-81. doi: 10.1136/heartjnl-2011-300344. Epub 2011 Sep 21. Heart. 2011. PMID: 21948962 Clinical Trial.
-
Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.Drug Des Devel Ther. 2010 May 25;4:61-70. doi: 10.2147/dddt.s6208. Drug Des Devel Ther. 2010. PMID: 20531962 Free PMC article. Review.
-
Clinical use of sildenafil in pulmonary artery hypertension.Expert Rev Respir Med. 2010 Feb;4(1):13-9. doi: 10.1586/ers.09.71. Expert Rev Respir Med. 2010. PMID: 20387288 Review.
Cited by
-
Pulmonary vasodilation in acute pulmonary embolism - a systematic review.Pulm Circ. 2020 Mar 4;10(1):2045894019899775. doi: 10.1177/2045894019899775. eCollection 2020 Jan-Mar. Pulm Circ. 2020. PMID: 32180938 Free PMC article. Review.
-
Sildenafil in the treatment of pulmonary hypertension.Vasc Health Risk Manag. 2006;2(4):411-22. doi: 10.2147/vhrm.2006.2.4.411. Vasc Health Risk Manag. 2006. PMID: 17323595 Free PMC article. Review.
-
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.J Vet Intern Med. 2020 Mar;34(2):549-573. doi: 10.1111/jvim.15725. Epub 2020 Feb 17. J Vet Intern Med. 2020. PMID: 32065428 Free PMC article.
-
Role of Phosphodiesterase-5 Inhibitors in Acute Right Ventricular Failure Due to Pulmonary Embolism.Am J Case Rep. 2019 Aug 4;20:1144-1147. doi: 10.12659/AJCR.915832. Am J Case Rep. 2019. PMID: 31377751 Free PMC article.
-
Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial.BMC Pulm Med. 2021 Feb 28;21(1):72. doi: 10.1186/s12890-021-01440-7. BMC Pulm Med. 2021. PMID: 33639897 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical